Disparate clinical presentation of neonatal hemochromatosis in twins

Pediatrics

Volumn 116, Issue 6, 2005, Pages

  Ekong, Udeme D ^a   Kelly, Susan ^a   Whitington, Peter F ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

fetoprotein; Ferritin; Neonatal hemochromatosis; Neonatal liver failure

Indexed keywords

ACETYLCYSTEINE; ALPHA FETOPROTEIN; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIOXIDANT; DEFEROXAMINE; FERRITIN; FRESH FROZEN PLASMA; GLUCOSE; PROSTAGLANDIN E1; SELENIUM; TOCOFERSOLAN;

ABDOMINAL RADIOGRAPHY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CRYOPRECIPITATE; DISEASE SEVERITY; DIZYGOTIC TWINS; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HEMOCHROMATOSIS; HOSPITAL DISCHARGE; HUMAN; IRON CHELATION; LIVER FAILURE; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEPSIS; TREATMENT OUTCOME; NEWBORN; TWINS;

DISEASES IN TWINS; FEMALE; HEMOCHROMATOSIS; HUMANS; INFANT, NEWBORN; MALE; TWINS, DIZYGOTIC;

EID: 33644668974     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-0784     Document Type: Article

References (29)

1. Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am. 2003;32:877- 889, vi-vii
2. Knisely AS. Neonatal hemochromatosis. Adv Pediatr. 1992;39:383-403
3. de Boissieu D, Knisely AS. Neonatal hemochromatosis. In: Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver Disease in Children. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001:641-647
4. Murray KF, Kowdley KV. Neonatal hemochromatosis. Pediatrics. 2001;108:960-964
5. Morris S, Akima S, Dahlstrom JE, Ellwood D, Kent A, Falk MC. Renal tubular dysgenesis and neonatal hemochromatosis without pulmonary hypoplasia. Pediatr Nephrol. 2004;19:341-344
6. Bale PM, Kan AE, Dorney SF. Renal proximal tubular dysgenesis associated with severe neonatal hemosiderotic liver disease. Pediatr Pathol. 1994;14:479-489
7. Colletti RB, Clemmons JJ. Familial neonatal hemochromatosis with survival. J Pediatr Gastroenterol Nutr. 1988;7:39-45
8. Allen KJ, Hart J, Whitington PF. Spectrum of outcomes in family of male siblings with neonatal hemochromatosis [abstract]. J Pediatr Gastroenterol Nutr. 1996;23:352
9. Kelly AL, Lunt PW, Rodrigues F, et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet. 2001;38:599-610
10. Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet. 2004;364:1690-1698
11. Verloes A, Temple IK, Hubert AF, et al. Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers. J Med Genet. 1996;33:444-449
12. Cox TM, Halsall DJ. Hemochromatosis - neonatal and young subjects. Blood Cells Mol Dis. 2002;29:411-417
13. Ferrell L, Schmidt K, Sheffield V, Packman S. Neonatal hemochromatosis: genetic counseling based on retrospective pathologic diagnosis. Am J Med Genet. 1992;44:429-433
14. Shneider BL. Genetic counseling in neonatal hemochromatosis. J Pediatr Gastroenterol Nutr. 2002;34:328
15. Hayes AM, Jaramillo D, Levy HL, Knisely AS. Neonatal hemochromatosis: diagnosis with MR imaging. AJR Am J Roentgenol. 1992;159:623-625
16. Shamieh I, Kibort PK, Suchy FJ, Freese DK. Antioxidant therapy for neonatal iron storage disease (NISD) [abstract]. Pediatr Res. 1993;33:109A
17. Flynn DM, Mohan N, McKiernan P, et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed. 2003;88:F124-F127
18. Knisely AS, O'Shea PA, Stocks JF, Dimmick JE. Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J Pediatr. 1988;113:871-874
19. Whitington PF, Malladi P. Neonatal hemochromatosis: is it an alloimmune disease? J Pediatr Gastroenterol Nutr. 2005;40:544-549
20. Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, Knisely AS. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr. 1998;26:85-89
21. Liley HG. Immune hemolytic disease. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, eds. Hematology of Infancy and Childhood. 6th ed. Philadelphia, PA: WB Saunders. 2003:56-85
22. Knisely AS. Iron and pediatric liver disease. Semin Liver Dis. 1994;14:229-235
23. Lee WS, McKiernan PJ, Kelly DA. Serum ferritin level in neonatal fulminant liver failure. Arch Dis Child Fetal Neonatal Ed. 2001;85:F226
24. Obiekwe BC, Malek N, Kitau MJ, Chard T. Maternal and fetal alphafetoprotein (AFP) levels at term: relation to sex, weight and gestation of the infant. Acta Obstet Gynecol Scand. 1985;64:251-253
25. Gitlin D. Normal biology of alpha-fetoprotein. Ann N Y Acad Sci. 1975;259:7-16
26. Allen K, Whitington PF. Evaluation of liver function. In: Polin R, Fox W, eds. Fetal and Neonatal Physiology. 2nd ed. Philadelphia, PA: WB Saunders; 1998:1530-1552
27. Witzleben CL, Uri A. Perinatal hemochromatosis: entity or end result? Hum Pathol. 1989;20:335-340
28. Hoogstraten J, de Sa DJ, Knisely AS. Fetal liver disease may precede extrahepatic siderosis in neonatal hemochromatosis. Gastroenterology. 1990;98:1699-1701
29. Shneider BL. Neonatal liver failure. Curr Opin Pediatr. 1996;8:495-501